Sickle Cell Care Management And Treatment Education

The "Sickle Cell Care Management and Treatment Education" bill aims to improve care for individuals with sickle cell disease by enhancing education and management programs. The bill includes provisions for increasing access to treatment, educating healthcare providers, supporting research initiatives, and promoting awareness of the disease. It seeks to address disparities in care and outcomes for those with sickle cell disease. If passed, this bill could lead to better quality of life and health outcomes for individuals affected by sickle cell disease through comprehensive care management and education efforts.

• 2023-11-06: Filed

• 2023-11-22: Referred to Healthcare Regulation Subcommittee

• 2023-11-22: Referred to Health Care Appropriations Subcommittee

• 2023-11-22: Referred to Health & Human Services Committee

• 2023-11-22: Now in Healthcare Regulation Subcommittee

• 2024-01-09: 1st Reading (Original Filed Version)

• 2024-01-30: PCS added to Healthcare Regulation Subcommittee agenda

• 2024-02-01: Favorable with CS by Healthcare Regulation Subcommittee

• 2024-02-02: Reported out of Healthcare Regulation Subcommittee

• 2024-02-02: Laid on Table under Rule 7.18(a)

• 2024-02-02: CS Filed

• 2024-02-05: Original reference removed: Health Care Appropriations Subcommittee

• 2024-02-05: Referred to Health & Human Services Committee

• 2024-02-05: Now in Health & Human Services Committee

• 2024-02-05: 1st Reading (Committee Substitute 1)

• 2024-03-08: Died in Health & Human Services Committee